Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| oligodendrocyte | 16 studies | 58% ± 18% | |
| endothelial cell | 10 studies | 23% ± 8% | |
| endothelial cell of artery | 8 studies | 24% ± 6% | |
| glutamatergic neuron | 8 studies | 33% ± 21% | |
| epithelial cell | 5 studies | 25% ± 7% | |
| endothelial cell of vascular tree | 5 studies | 22% ± 12% | |
| fibroblast | 4 studies | 20% ± 4% | |
| astrocyte | 4 studies | 22% ± 7% | |
| microglial cell | 3 studies | 18% ± 2% | |
| cardiac muscle cell | 3 studies | 22% ± 2% | |
| cholangiocyte | 3 studies | 43% ± 23% | |
| GABAergic neuron | 3 studies | 23% ± 5% | |
| transit amplifying cell | 3 studies | 26% ± 6% | |
| brush cell | 3 studies | 26% ± 6% | |
| interneuron | 3 studies | 26% ± 11% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 11 studies | 36% ± 14% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 2333.69 | 1443 / 1445 | 100% | 15.88 | 183 / 183 |
| prostate | 100% | 2584.28 | 245 / 245 | 100% | 14.84 | 501 / 502 |
| stomach | 100% | 1551.98 | 359 / 359 | 100% | 14.64 | 285 / 286 |
| intestine | 100% | 2483.85 | 966 / 966 | 100% | 14.07 | 525 / 527 |
| pancreas | 100% | 1327.34 | 327 / 328 | 99% | 12.17 | 177 / 178 |
| bladder | 100% | 3304.00 | 21 / 21 | 99% | 10.21 | 499 / 504 |
| uterus | 100% | 2685.22 | 170 / 170 | 98% | 9.62 | 448 / 459 |
| thymus | 100% | 1837.44 | 651 / 653 | 98% | 8.49 | 591 / 605 |
| lung | 97% | 1370.78 | 563 / 578 | 99% | 9.16 | 1141 / 1155 |
| breast | 96% | 2141.68 | 442 / 459 | 100% | 15.67 | 1115 / 1118 |
| ovary | 99% | 1329.16 | 178 / 180 | 93% | 5.53 | 398 / 430 |
| brain | 99% | 5758.61 | 2620 / 2642 | 90% | 9.68 | 632 / 705 |
| kidney | 99% | 1368.73 | 88 / 89 | 76% | 4.20 | 682 / 901 |
| skin | 99% | 1853.96 | 1792 / 1809 | 71% | 3.85 | 335 / 472 |
| liver | 87% | 684.76 | 197 / 226 | 80% | 5.89 | 326 / 406 |
| adrenal gland | 100% | 1861.88 | 258 / 258 | 51% | 2.05 | 118 / 230 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 9.45 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 3.10 | 1 / 1 |
| blood vessel | 100% | 2922.15 | 1331 / 1335 | 0% | 0 | 0 / 0 |
| spleen | 100% | 1185.95 | 240 / 241 | 0% | 0 | 0 / 0 |
| adipose | 96% | 1311.19 | 1158 / 1204 | 0% | 0 | 0 / 0 |
| heart | 96% | 1927.58 | 826 / 861 | 0% | 0 | 0 / 0 |
| muscle | 91% | 1458.88 | 733 / 803 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 69% | 2.85 | 20 / 29 |
| eye | 0% | 0 | 0 / 0 | 56% | 4.00 | 45 / 80 |
| peripheral blood | 54% | 554.81 | 506 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0048488 | Biological process | synaptic vesicle endocytosis |
| GO_0061024 | Biological process | membrane organization |
| GO_0046856 | Biological process | phosphatidylinositol dephosphorylation |
| GO_0036092 | Biological process | phosphatidylinositol-3-phosphate biosynthetic process |
| GO_0006661 | Biological process | phosphatidylinositol biosynthetic process |
| GO_0098793 | Cellular component | presynapse |
| GO_0005856 | Cellular component | cytoskeleton |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0045121 | Cellular component | membrane raft |
| GO_0048471 | Cellular component | perinuclear region of cytoplasm |
| GO_0005829 | Cellular component | cytosol |
| GO_0042995 | Cellular component | cell projection |
| GO_0004438 | Molecular function | phosphatidylinositol-3-phosphate phosphatase activity |
| GO_0004439 | Molecular function | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity |
| GO_0030165 | Molecular function | PDZ domain binding |
| GO_0034596 | Molecular function | phosphatidylinositol phosphate 4-phosphatase activity |
| GO_0052629 | Molecular function | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity |
| GO_0003723 | Molecular function | RNA binding |
| GO_0043813 | Molecular function | phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0017124 | Molecular function | SH3 domain binding |
| Gene name | SYNJ2 |
| Protein name | phosphoinositide 5-phosphatase (EC 3.1.3.36) Phosphatidylinositol-3-phosphatase SAC1 (EC 3.1.3.64) (Phosphatidylinositol-4-phosphate phosphatase) (Suppressor of actin mutations 1-like protein) Synaptojanin 2 Synaptojanin-2 (EC 3.1.3.36) (Synaptic inositol 1,4,5-trisphosphate 5-phosphatase 2) |
| Synonyms | KIAA0348 |
| Description | FUNCTION: Inositol 5-phosphatase which may be involved in distinct membrane trafficking and signal transduction pathways. May mediate the inhibitory effect of Rac1 on endocytosis. |
| Accessions | H0YEV8 O15056 ENST00000640338.1 [O15056-3] ENST00000367122.6 ENST00000449320.2 ENST00000367113.5 A0A1W2PR85 Q5TA15 ENST00000485863.1 ENST00000355585.9 [O15056-1] ENST00000638626.1 H7BY56 E7ER60 |